Literature DB >> 22762402

Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes.

Brendan C Visser1, Yifei Ma, Yulia Zak, George A Poultsides, Jeffrey A Norton, Kim F Rhoads.   

Abstract

INTRODUCTION: There are little data available regarding compliance with the National Comprehensive Cancer Network (NCCN) guidelines. We investigated variation in the management of pancreatic cancer (PC) among large hospitals in California, USA, specifically to evaluate whether compliance with NCCN guidelines correlates with patient outcomes.
METHODS: The California Cancer Registry was used to identify patients treated for PC from 2001 to 2006. Only hospitals with ≥ 400 beds were included to limit evaluation to centres possessing resources to provide multimodality care (n= 50). Risk-adjusted multivariable models evaluated predictors of adherence to stage-specific NCCN guidelines for PC and mortality.
RESULTS: In all, 3706 patients were treated for PC in large hospitals during the study period. Compliance with NCCN guidelines was only 34.5%. Patients were less likely to get recommended therapy with advanced age and low socioeconomic status (SES). Using multilevel analysis, controlling for patient factors (including demographics and comorbidities), hospital factors (e.g. size, academic affiliation and case volume), compliance with NCCN guidelines was associated with a reduced risk of mortality [odds ratio (OR) for death 0.64 (0.53-0.77, P < 0.0001)].
CONCLUSIONS: There is relatively poor overall compliance with the NCCN PC guidelines in California's large hospitals. Higher compliance rates are correlated with improved survival. Compliance is an important potential measure of the quality of care.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 22762402      PMCID: PMC3406351          DOI: 10.1111/j.1477-2574.2012.00496.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  37 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

Review 2.  Measuring the quality of surgical care: structure, process, or outcomes?

Authors:  John D Birkmeyer; Justin B Dimick; Nancy J O Birkmeyer
Journal:  J Am Coll Surg       Date:  2004-04       Impact factor: 6.113

3.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

4.  Surgical site infection prevention: time to move beyond the surgical care improvement program.

Authors:  Mary T Hawn; Catherine C Vick; Joshua Richman; William Holman; Rhiannon J Deierhoi; Laura A Graham; William G Henderson; Kamal M F Itani
Journal:  Ann Surg       Date:  2011-09       Impact factor: 12.969

5.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Authors:  H A Burris; M J Moore; J Andersen; M R Green; M L Rothenberg; M R Modiano; M C Cripps; R K Portenoy; A M Storniolo; P Tarassoff; R Nelson; F A Dorr; C D Stephens; D D Von Hoff
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

6.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

7.  Hospital volume influences outcome in patients undergoing pancreatic resection for cancer.

Authors:  R E Glasgow; S J Mulvihill
Journal:  West J Med       Date:  1996-11

8.  Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.

Authors:  M H Kalser; S S Ellenberg
Journal:  Arch Surg       Date:  1985-08

9.  Importance of hospital volume in the overall management of pancreatic cancer.

Authors:  J A Sosa; H M Bowman; T A Gordon; E B Bass; C J Yeo; K D Lillemoe; H A Pitt; J M Tielsch; J L Cameron
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

10.  Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure.

Authors:  Louise C Walter; Natalie P Davidowitz; Paul A Heineken; Kenneth E Covinsky
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

View more
  31 in total

1.  Identification of Educational Gaps Among Oncologists Who Manage Patients with Pancreatic Cancer.

Authors:  Justin A Barnes; Melissa L Ellis; Sharon Hwang; Joan Emarine; Patti Merwin; Gregory D Salinas; Benjamin L Musher
Journal:  J Gastrointest Cancer       Date:  2019-03

2.  An audit of referral and treatment patterns of high-risk prostate cancer patients in Alberta.

Authors:  Majed Alghamdi; Amandeep Taggar; Derek Tilley; Marc Kerba; Xanthoula Kostaras; Geoffrey Gotto; Michael Sia
Journal:  Can Urol Assoc J       Date:  2016 Nov-Dec       Impact factor: 1.862

3.  Contribution of Geographic Location to Disparities in Ovarian Cancer Treatment.

Authors:  Carolina Villanueva; Jenny Chang; Scott M Bartell; Argyrios Ziogas; Robert Bristow; Verónica M Vieira
Journal:  J Natl Compr Canc Netw       Date:  2019-11-01       Impact factor: 11.908

4.  How do integrated health care systems address racial and ethnic disparities in colon cancer?

Authors:  Kim F Rhoads; Manali I Patel; Yifei Ma; Laura A Schmidt
Journal:  J Clin Oncol       Date:  2015-01-26       Impact factor: 44.544

5.  Analyzing the Impact of Compliance with National Guidelines for Pancreatic Cancer Care Using the National Cancer Database.

Authors:  Kathryn Jaap; Marcus Fluck; Marie Hunsinger; Jeffrey Wild; Tania Arora; Mohsen Shabahang; Joseph Blansfield
Journal:  J Gastrointest Surg       Date:  2018-03-28       Impact factor: 3.452

6.  Insurance Coverage Type Impacts Hospitalization Patterns Among Patients with Hepatopancreatic Malignancies.

Authors:  Rittal Mehta; Kota Sahara; Katiuscha Merath; J Madison Hyer; Diamantis I Tsilimigras; Anghela Z Paredes; Aslam Ejaz; Jordan M Cloyd; Mary Dillhoff; Allan Tsung; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-06-13       Impact factor: 3.452

Review 7.  Cystic pancreatic lesions: From increased diagnosis rate to new dilemmas.

Authors:  S Nougaret; L Mannelli; M-A Pierredon; V Schembri; B Guiu
Journal:  Diagn Interv Imaging       Date:  2016-11-11       Impact factor: 4.026

8.  Diagnosis, Preoperative Evaluation, and Assessment of Resectability of Pancreatic and Periampullary Cancer.

Authors:  Ashish Verma; Sunit Shukla; Nimisha Verma
Journal:  Indian J Surg       Date:  2015-10-08       Impact factor: 0.656

9.  Health Insurance Expansion and Treatment of Pancreatic Cancer: Does Increased Access Lead to Improved Care?

Authors:  Andrew P Loehrer; David C Chang; Matthew M Hutter; Zirui Song; Keith D Lillemoe; Andrew L Warshaw; Cristina R Ferrone
Journal:  J Am Coll Surg       Date:  2015-10-09       Impact factor: 6.113

10.  Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients.

Authors:  Yong Yue; Arsen Osipov; Benedick Fraass; Howard Sandler; Xiao Zhang; Nicholas Nissen; Andrew Hendifar; Richard Tuli
Journal:  J Gastrointest Oncol       Date:  2017-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.